Shrinking a Qidni
Morteza Ahmadi, CEO of Quidni labs, aims to design a small blood purification device that will offer longer treatment times and ultimately replace dialysis in clinics—at 40% less cost. With grants from programs including the Canadian Space Agency, the vision of Qidni is to “surpass current technology to become the new standard of treatment and help millions of patients on dialysis live a normal life.”
Read the full article » | Posted 03-16-2020
Related Articles
- Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
- New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
- Emerging Biomarker Research in PD Posted 03-12-2026
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026

